comparemela.com

Jeff Knight, the Chief Operating Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), has sold 32,359 shares of the company on March 22, 2024, according to a recent SEC filing.

Related Keywords

,Jeff Knight ,Pharmaceuticals ,Nsider Transaction ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.